Optimizing Extended Adjuvant Endocrine Therapy in Patients With Breast Cancer

NCT06223698 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

3832

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Letrozole
DRUG: Anastrozole
DRUG: Exemestane
DRUG: Tamoxifen

Sponsor

Region Örebro County

Collaborators

[object Object]
[object Object]